GALMED PHARMACEUTICALS LTD. Payments to Acquire Investments
GALMED PHARMACEUTICALS LTD. (GLMD) reported Payments to Acquire Investments of $6.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-03-31
| Period end | Payments to Acquire Investments 6 month | Payments to Acquire Investments 12 month |
|---|---|---|
| 2025-12-31 | $6.00M 20-F · filed 2026-03-31 | |
| 2024-12-31 | $6.00M 20-F · filed 2025-04-02 | |
| 2023-12-31 | $60.00M 20-F · filed 2024-04-04 | |
| 2023-06-30 | $6.00M 6-K · filed 2023-08-09 |